Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (2016)
- Authors:
- USP affiliated authors: GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidades: FORP; FMRP
- DOI: 10.1371/journal.pone.0158779
- Subjects: CANABINOIDES; FLUORAÇÃO; NEUROPSIQUIATRIA; FARMACOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2016
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BREUER, Aviva et al. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, v. 11, 2016Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0158779. Acesso em: 13 fev. 2026. -
APA
Breuer, A., Haj, C. G., Fogaça, M. V., Gomes, F. V., Silva, N. R., Pedrazzi, J. F., et al. (2016). Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS ONE, 11. doi:10.1371/journal.pone.0158779 -
NLM
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2026 fev. 13 ] Available from: https://doi.org/10.1371/journal.pone.0158779 -
Vancouver
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JEC, Crippa JA de S, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol derivatives: enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects [Internet]. PLoS ONE. 2016 ; 11[citado 2026 fev. 13 ] Available from: https://doi.org/10.1371/journal.pone.0158779 - Correction: Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Biological bases for a possible effect of cannabidiol in Parkinson’s disease
Informações sobre o DOI: 10.1371/journal.pone.0158779 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002789246.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
